United States Ocular Drug Delivery Technology Market Report 2017

August 2017 | 97 pages | ID: U96E008FFA8EN
QYResearch

Abstracts

In this report, the United States Ocular Drug Delivery Technology market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Ocular Drug Delivery Technology in these regions, from 2012 to 2022 (forecast).

United States Ocular Drug Delivery Technology market competition by top manufacturers/players, with Ocular Drug Delivery Technology sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• OCULAR THERAPEUTIX
• Alimera Sciences
• Allergan
• EyeGate Pharma
• Valeant Pharmaceuticals International
• Envisia Therapeutics
• Clearside Biomedical
• Graybug Vision
• Graybug Vision
• Taiwan Liposome Company

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Topical
• Ocular Inserts
• Iontophoresis
• Intraocular Implants

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Ocular Drug Delivery Technology for each application, including

• Hospitals
• Ambulatory Surgical Centers
• Clinics

Contents

United States Ocular Drug Delivery Technology Market Report 2017

1 OCULAR DRUG DELIVERY TECHNOLOGY OVERVIEW

1.1 Product Overview and Scope of Ocular Drug Delivery Technology
1.2 Classification of Ocular Drug Delivery Technology by Product Category
  1.2.1 United States Ocular Drug Delivery Technology Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Ocular Drug Delivery Technology Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Topical
  1.2.4 Ocular Inserts
  1.2.5 Iontophoresis
  1.2.6 Intraocular Implants
1.3 United States Ocular Drug Delivery Technology Market by Application/End Users
  1.3.1 United States Ocular Drug Delivery Technology Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Clinics
1.4 United States Ocular Drug Delivery Technology Market by Region
  1.4.1 United States Ocular Drug Delivery Technology Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Ocular Drug Delivery Technology Status and Prospect (2012-2022)
  1.4.3 Southwest Ocular Drug Delivery Technology Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Ocular Drug Delivery Technology Status and Prospect (2012-2022)
  1.4.5 New England Ocular Drug Delivery Technology Status and Prospect (2012-2022)
  1.4.6 The South Ocular Drug Delivery Technology Status and Prospect (2012-2022)
  1.4.7 The Midwest Ocular Drug Delivery Technology Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Ocular Drug Delivery Technology (2012-2022)
  1.5.1 United States Ocular Drug Delivery Technology Sales and Growth Rate (2012-2022)
  1.5.2 United States Ocular Drug Delivery Technology Revenue and Growth Rate (2012-2022)

2 UNITED STATES OCULAR DRUG DELIVERY TECHNOLOGY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Ocular Drug Delivery Technology Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Ocular Drug Delivery Technology Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Ocular Drug Delivery Technology Average Price by Players/Suppliers (2012-2017)
2.4 United States Ocular Drug Delivery Technology Market Competitive Situation and Trends
  2.4.1 United States Ocular Drug Delivery Technology Market Concentration Rate
  2.4.2 United States Ocular Drug Delivery Technology Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Ocular Drug Delivery Technology Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OCULAR DRUG DELIVERY TECHNOLOGY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Ocular Drug Delivery Technology Sales and Market Share by Region (2012-2017)
3.2 United States Ocular Drug Delivery Technology Revenue and Market Share by Region (2012-2017)
3.3 United States Ocular Drug Delivery Technology Price by Region (2012-2017)

4 UNITED STATES OCULAR DRUG DELIVERY TECHNOLOGY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Ocular Drug Delivery Technology Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Ocular Drug Delivery Technology Revenue and Market Share by Type (2012-2017)
4.3 United States Ocular Drug Delivery Technology Price by Type (2012-2017)
4.4 United States Ocular Drug Delivery Technology Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OCULAR DRUG DELIVERY TECHNOLOGY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Ocular Drug Delivery Technology Sales and Market Share by Application (2012-2017)
5.2 United States Ocular Drug Delivery Technology Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OCULAR DRUG DELIVERY TECHNOLOGY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 OCULAR THERAPEUTIX
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ocular Drug Delivery Technology Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 OCULAR THERAPEUTIX Ocular Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Alimera Sciences
  6.2.2 Ocular Drug Delivery Technology Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Alimera Sciences Ocular Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Allergan
  6.3.2 Ocular Drug Delivery Technology Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Allergan Ocular Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 EyeGate Pharma
  6.4.2 Ocular Drug Delivery Technology Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 EyeGate Pharma Ocular Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Valeant Pharmaceuticals International
  6.5.2 Ocular Drug Delivery Technology Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Valeant Pharmaceuticals International Ocular Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Envisia Therapeutics
  6.6.2 Ocular Drug Delivery Technology Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Envisia Therapeutics Ocular Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Clearside Biomedical
  6.7.2 Ocular Drug Delivery Technology Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Clearside Biomedical Ocular Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Graybug Vision
  6.8.2 Ocular Drug Delivery Technology Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Graybug Vision Ocular Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Graybug Vision
  6.9.2 Ocular Drug Delivery Technology Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Graybug Vision Ocular Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Taiwan Liposome Company
  6.10.2 Ocular Drug Delivery Technology Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Taiwan Liposome Company Ocular Drug Delivery Technology Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 OCULAR DRUG DELIVERY TECHNOLOGY MANUFACTURING COST ANALYSIS

7.1 Ocular Drug Delivery Technology Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ocular Drug Delivery Technology

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ocular Drug Delivery Technology Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ocular Drug Delivery Technology Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Ocular Drug Delivery Technology Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Ocular Drug Delivery Technology Sales Volume Forecast by Type (2017-2022)
11.3 United States Ocular Drug Delivery Technology Sales Volume Forecast by Application (2017-2022)
11.4 United States Ocular Drug Delivery Technology Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Ocular Drug Delivery Technology
Figure United States Ocular Drug Delivery Technology Market Size (K Units) by Type (2012-2022)
Figure United States Ocular Drug Delivery Technology Sales Volume Market Share by Type (Product Category) in 2016
Figure Topical Product Picture
Figure Ocular Inserts Product Picture
Figure Iontophoresis Product Picture
Figure Intraocular Implants Product Picture
Figure United States Ocular Drug Delivery Technology Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Ocular Drug Delivery Technology by Application in 2016
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Clinics Examples
Figure United States Ocular Drug Delivery Technology Market Size (Million USD) by Region (2012-2022)
Figure The West Ocular Drug Delivery Technology Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Ocular Drug Delivery Technology Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Ocular Drug Delivery Technology Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Ocular Drug Delivery Technology Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Ocular Drug Delivery Technology Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Ocular Drug Delivery Technology Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ocular Drug Delivery Technology Sales (K Units) and Growth Rate (2012-2022)
Figure United States Ocular Drug Delivery Technology Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ocular Drug Delivery Technology Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Ocular Drug Delivery Technology Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Ocular Drug Delivery Technology Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ocular Drug Delivery Technology Sales Share by Players/Suppliers
Figure 2017 United States Ocular Drug Delivery Technology Sales Share by Players/Suppliers
Figure United States Ocular Drug Delivery Technology Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Ocular Drug Delivery Technology Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Ocular Drug Delivery Technology Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ocular Drug Delivery Technology Revenue Share by Players/Suppliers
Figure 2017 United States Ocular Drug Delivery Technology Revenue Share by Players/Suppliers
Table United States Market Ocular Drug Delivery Technology Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Ocular Drug Delivery Technology Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Ocular Drug Delivery Technology Market Share of Top 3 Players/Suppliers
Figure United States Ocular Drug Delivery Technology Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Ocular Drug Delivery Technology Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Ocular Drug Delivery Technology Product Category
Table United States Ocular Drug Delivery Technology Sales (K Units) by Region (2012-2017)
Table United States Ocular Drug Delivery Technology Sales Share by Region (2012-2017)
Figure United States Ocular Drug Delivery Technology Sales Share by Region (2012-2017)
Figure United States Ocular Drug Delivery Technology Sales Market Share by Region in 2016
Table United States Ocular Drug Delivery Technology Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Ocular Drug Delivery Technology Revenue Share by Region (2012-2017)
Figure United States Ocular Drug Delivery Technology Revenue Market Share by Region (2012-2017)
Figure United States Ocular Drug Delivery Technology Revenue Market Share by Region in 2016
Table United States Ocular Drug Delivery Technology Price (USD/Unit) by Region (2012-2017)
Table United States Ocular Drug Delivery Technology Sales (K Units) by Type (2012-2017)
Table United States Ocular Drug Delivery Technology Sales Share by Type (2012-2017)
Figure United States Ocular Drug Delivery Technology Sales Share by Type (2012-2017)
Figure United States Ocular Drug Delivery Technology Sales Market Share by Type in 2016
Table United States Ocular Drug Delivery Technology Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Ocular Drug Delivery Technology Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ocular Drug Delivery Technology by Type (2012-2017)
Figure Revenue Market Share of Ocular Drug Delivery Technology by Type in 2016
Table United States Ocular Drug Delivery Technology Price (USD/Unit) by Types (2012-2017)
Figure United States Ocular Drug Delivery Technology Sales Growth Rate by Type (2012-2017)
Table United States Ocular Drug Delivery Technology Sales (K Units) by Application (2012-2017)
Table United States Ocular Drug Delivery Technology Sales Market Share by Application (2012-2017)
Figure United States Ocular Drug Delivery Technology Sales Market Share by Application (2012-2017)
Figure United States Ocular Drug Delivery Technology Sales Market Share by Application in 2016
Table United States Ocular Drug Delivery Technology Sales Growth Rate by Application (2012-2017)
Figure United States Ocular Drug Delivery Technology Sales Growth Rate by Application (2012-2017)
Table OCULAR THERAPEUTIX Basic Information List
Table OCULAR THERAPEUTIX Ocular Drug Delivery Technology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure OCULAR THERAPEUTIX Ocular Drug Delivery Technology Sales Growth Rate (2012-2017)
Figure OCULAR THERAPEUTIX Ocular Drug Delivery Technology Sales Market Share in United States (2012-2017)
Figure OCULAR THERAPEUTIX Ocular Drug Delivery Technology Revenue Market Share in United States (2012-2017)
Table Alimera Sciences Basic Information List
Table Alimera Sciences Ocular Drug Delivery Technology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Technology Sales Growth Rate (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Technology Sales Market Share in United States (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Technology Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Ocular Drug Delivery Technology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Ocular Drug Delivery Technology Sales Growth Rate (2012-2017)
Figure Allergan Ocular Drug Delivery Technology Sales Market Share in United States (2012-2017)
Figure Allergan Ocular Drug Delivery Technology Revenue Market Share in United States (2012-2017)
Table EyeGate Pharma Basic Information List
Table EyeGate Pharma Ocular Drug Delivery Technology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Technology Sales Growth Rate (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Technology Sales Market Share in United States (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Technology Revenue Market Share in United States (2012-2017)
Table Valeant Pharmaceuticals International Basic Information List
Table Valeant Pharmaceuticals International Ocular Drug Delivery Technology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International Ocular Drug Delivery Technology Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International Ocular Drug Delivery Technology Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceuticals International Ocular Drug Delivery Technology Revenue Market Share in United States (2012-2017)
Table Envisia Therapeutics Basic Information List
Table Envisia Therapeutics Ocular Drug Delivery Technology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Technology Sales Growth Rate (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Technology Sales Market Share in United States (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Technology Revenue Market Share in United States (2012-2017)
Table Clearside Biomedical Basic Information List
Table Clearside Biomedical Ocular Drug Delivery Technology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Technology Sales Growth Rate (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Technology Sales Market Share in United States (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Technology Revenue Market Share in United States (2012-2017)
Table Graybug Vision Basic Information List
Table Graybug Vision Ocular Drug Delivery Technology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Graybug Vision Ocular Drug Delivery Technology Sales Growth Rate (2012-2017)
Figure Graybug Vision Ocular Drug Delivery Technology Sales Market Share in United States (2012-2017)
Figure Graybug Vision Ocular Drug Delivery Technology Revenue Market Share in United States (2012-2017)
Table Graybug Vision Basic Information List
Table Graybug Vision Ocular Drug Delivery Technology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Graybug Vision Ocular Drug Delivery Technology Sales Growth Rate (2012-2017)
Figure Graybug Vision Ocular Drug Delivery Technology Sales Market Share in United States (2012-2017)
Figure Graybug Vision Ocular Drug Delivery Technology Revenue Market Share in United States (2012-2017)
Table Taiwan Liposome Company Basic Information List
Table Taiwan Liposome Company Ocular Drug Delivery Technology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Technology Sales Growth Rate (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Technology Sales Market Share in United States (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Technology Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ocular Drug Delivery Technology
Figure Manufacturing Process Analysis of Ocular Drug Delivery Technology
Figure Ocular Drug Delivery Technology Industrial Chain Analysis
Table Raw Materials Sources of Ocular Drug Delivery Technology Major Players/Suppliers in 2016
Table Major Buyers of Ocular Drug Delivery Technology
Table Distributors/Traders List
Figure United States Ocular Drug Delivery Technology Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Ocular Drug Delivery Technology Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Ocular Drug Delivery Technology Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Ocular Drug Delivery Technology Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Ocular Drug Delivery Technology Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Ocular Drug Delivery Technology Sales Volume (K Units) Forecast by Type in 2022
Table United States Ocular Drug Delivery Technology Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Ocular Drug Delivery Technology Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Ocular Drug Delivery Technology Sales Volume (K Units) Forecast by Application in 2022
Table United States Ocular Drug Delivery Technology Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Ocular Drug Delivery Technology Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ocular Drug Delivery Technology Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ocular Drug Delivery Technology Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources